Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca, Ironwood to seek Chinese approval for linaclotide following positive results in late-stage IBS-C trial
AstraZeneca, Ironwood to seek Chinese approval for linaclotide following positive results in late-stage IBS-C trial
AstraZeneca, Ironwood to seek Chinese approval for linaclotide following positive results in late-stage IBS-C trial
Submitted by
admin
on July 8, 2015 - 9:53am
Source:
First Word Pharma
News Tags:
AstraZeneca
Ironwood
China
linaclotide
IBS-C
Headline:
AstraZeneca, Ironwood to seek Chinese approval for linaclotide following positive results in late-stage IBS-C trial
Do Not Allow Advertisers to Use My Personal information
